Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Funada

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
JAMA Internal Medicine|December 14, 2020
Implementing Group-Based Pelvic Floor Muscle Training in Clinical PracticeSatoshi Funada, Yan Luo
The Journal of Urology|March 20, 2020
Re: Is There an Association between Urinary Incontinence and Mortality? A Retrospective Cohort StudyTakashi Yoshioka, Satoshi Funada
The Lancet. Oncology|June 4, 2021
Adjuvant immunotherapy in muscle-invasive urothelial carcinomaSatoshi Funada, Yan Luo
European Urology|November 19, 2020
Re: Guohua Zeng, Chao Cai, Xianzhong Duan, et al. Mini Percutaneous Nephrolithotomy Is a Noninferior Modality to Standard Percutaneous Nephrolithotomy for the Management of 20-40mm Renal Calculi: A Multicenter Randomized Controlled Trial. Eur Urol 2021;79:114-21Satoshi Funada, Takashi Yoshioka, Yan Luo
The Journal of Urology|November 12, 2020
Systematic Review and Meta-Analysis Comparing Percutaneous Nephrolithotomy, Retrograde Intrarenal Surgery and Shock Wave Lithotripsy for Lower Pole Renal Stones Less Than 2 cm in Maximum Diameter. LetterTakashi Yoshioka, Satoshi Funada, Yan Luo
European Urology|September 22, 2020
Re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Eur Urol 2020;78:540-3Satoshi Funada, Takashi Yoshioka, Yan Luo
European Urology|March 2, 2021
Re: Cosimo De Nunzio, Benjamin Brucker, Thomas Bschleipfer, et al. Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men. Eur Urol 2021;79:492-504Satoshi Funada, Takashi Yoshioka, Yan Luo
European Urology|December 28, 2020
Re: Marcus J. Drake, Amanda L. Lewis, Grace J. Young, et al. Diagnostic Assessment of Lower Urinary Tract Symptoms in Men Considering Prostate Surgery: A Noninferiority Randomised Controlled Trial of Urodynamics in 26 Hospitals. Eur Urol 2020;78:701-10Satoshi Funada, Takashi Yoshioka, Yan Luo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2020
The Inherent Problems With the Generalizability of the CALL Score: Towards Reliable Clinical Prediction Models for Coronavirus Disease 2019 (COVID-19)Takashi Yoshioka, Satoshi Funada, Yan Luo
JAMA Oncology|February 11, 2021
Evaluation of Efficacy and Safety of Nab-Paclitaxel vs Paclitaxel in Platinum-Refractory Metastatic Urothelial CancerSatoshi Funada, Takashi Yoshioka, Yan Luo
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
JAMA Internal Medicine|December 14, 2020
Implementing Group-Based Pelvic Floor Muscle Training in Clinical PracticeSatoshi Funada, Yan Luo
The Journal of Urology|March 20, 2020
Re: Is There an Association between Urinary Incontinence and Mortality? A Retrospective Cohort StudyTakashi Yoshioka, Satoshi Funada
The Lancet. Oncology|June 4, 2021
Adjuvant immunotherapy in muscle-invasive urothelial carcinomaSatoshi Funada, Yan Luo
European Urology|November 19, 2020
Re: Guohua Zeng, Chao Cai, Xianzhong Duan, et al. Mini Percutaneous Nephrolithotomy Is a Noninferior Modality to Standard Percutaneous Nephrolithotomy for the Management of 20-40mm Renal Calculi: A Multicenter Randomized Controlled Trial. Eur Urol 2021;79:114-21Satoshi Funada, Takashi Yoshioka, Yan Luo
The Journal of Urology|November 12, 2020
Systematic Review and Meta-Analysis Comparing Percutaneous Nephrolithotomy, Retrograde Intrarenal Surgery and Shock Wave Lithotripsy for Lower Pole Renal Stones Less Than 2 cm in Maximum Diameter. LetterTakashi Yoshioka, Satoshi Funada, Yan Luo
European Urology|September 22, 2020
Re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Eur Urol 2020;78:540-3Satoshi Funada, Takashi Yoshioka, Yan Luo
European Urology|March 2, 2021
Re: Cosimo De Nunzio, Benjamin Brucker, Thomas Bschleipfer, et al. Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men. Eur Urol 2021;79:492-504Satoshi Funada, Takashi Yoshioka, Yan Luo
European Urology|December 28, 2020
Re: Marcus J. Drake, Amanda L. Lewis, Grace J. Young, et al. Diagnostic Assessment of Lower Urinary Tract Symptoms in Men Considering Prostate Surgery: A Noninferiority Randomised Controlled Trial of Urodynamics in 26 Hospitals. Eur Urol 2020;78:701-10Satoshi Funada, Takashi Yoshioka, Yan Luo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2020
The Inherent Problems With the Generalizability of the CALL Score: Towards Reliable Clinical Prediction Models for Coronavirus Disease 2019 (COVID-19)Takashi Yoshioka, Satoshi Funada, Yan Luo
JAMA Oncology|February 11, 2021
Evaluation of Efficacy and Safety of Nab-Paclitaxel vs Paclitaxel in Platinum-Refractory Metastatic Urothelial CancerSatoshi Funada, Takashi Yoshioka, Yan Luo
Pageof 7